Compare AU
Compare DRUG vs. GIVE
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are DRUG and GIVE. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | GIVE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 2 |
Median incremental investment | $967.00 | $523.25 |
Median investment frequency | Monthly | Quarterly |
Median total investment | $1,875.72 | $797.50 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
DRUG | GIVE | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | GIVE.AX was created on 2021-11-29 by Perpetual. The fund's investment portfolio concentrates primarily on total market equity. Aims to: provide long-term capital growth and regular income through investment predominantly in quality Australian shares that meet Perpetuals ESG and values-based criteria outperform the S&P/ASX 300 Accumulation Index (before fees and taxes) over rolling three-year periods. |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | Perpetual Esg Australian Share Fund (Managed Fund) (100 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0.57 % | 0.65 % |
Key Summary
DRUG | GIVE | |
|---|---|---|
Issuer | BetaShares | Perpetual |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | S&P/ASX 300 Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.65 % |
Price | $8.12 | $3.19 |
Size | $182.401 million | N/A |
10Y return | N/A | N/A |
Annual distribution/ dividend yield (5Y) | 1.90 % | 5.50 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 28/11/2021 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | GIVE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 2 |
Median incremental investment | $967.00 | $523.25 |
Median investment frequency | Monthly | Quarterly |
Median total investment | $1,875.72 | $797.50 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
DRUG | GIVE | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | GIVE |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |